ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 036,94
0,38%
Dow Jones
38 966,50
0,41%
DAX
18 654,92
0,46%
Brent Oil
78,665
0,13%
Bitcoin
71 224,31
0,20%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NYSE
  6. Labcorp Holdings Inc (LH)

  7. Labcorp Holdings Inc (LH) Actualités

LH

Labcorp (LH)

Labcorp Holdings Inc
De:
Trier par:
 Showing the most relevant articles for your search:NYSE:LH
DateHeureSourceTitreSymboleSociété
04/06/202413h41Edgar (US Regulatory)Form 8-K - Current reportNYSE:LHLabcorp Holdings Inc
03/06/202423h23Edgar (US Regulatory)Form 15-12G - Securities registration termination [Section 12(g)]NYSE:LHLabcorp Holdings Inc
03/06/202413h00PR Newswire (US)Labcorp Announces New Strategic Service Offerings within Precision Oncology PortfolioNYSE:LHLabcorp Holdings Inc
30/05/202419h18Edgar (US Regulatory)Form SD - Specialized disclosure reportNYSE:LHLabcorp Holdings Inc
30/05/202413h00PR Newswire (US)Labcorp to Present Multiple Abstracts across Precision Oncology at the 2024 ASCO Annual MeetingNYSE:LHLabcorp Holdings Inc
28/05/202412h59PR Newswire (US)Labcorp to Speak at the 44th Annual William Blair Growth Stock ConferenceNYSE:LHLabcorp Holdings Inc
17/05/202422h57Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNYSE:LHLabcorp Holdings Inc
17/05/202422h45Edgar (US Regulatory)Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuersNYSE:LHLabcorp Holdings Inc
17/05/202422h41Edgar (US Regulatory)Form POSASR - Post-effective Amendment to an automatic shelf registration statementNYSE:LHLabcorp Holdings Inc
17/05/202422h32Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNYSE:LHLabcorp Holdings Inc
17/05/202422h10Edgar (US Regulatory)Form 8-K12B - Notification that a class of securities of successor issuer is deemed to be registered pursuant to section 12(b)NYSE:LHLabcorp Holdings Inc
16/05/202414h02Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:LHLabcorp Holdings Inc
15/05/202414h00PR Newswire (US)Labcorp Introduces First Trimester Screening Test to Assess Preeclampsia Risk during PregnancyNYSE:LHLabcorp Holdings Inc
14/05/202418h40Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:LHLabcorp Holdings Inc
08/05/202412h59PR Newswire (US)Labcorp to Webcast Its Annual Meeting of ShareholdersNYSE:LHLabcorp Holdings Inc
07/05/202422h05PR Newswire (US)Invitae Receives Court Approval for Sale to LabcorpNYSE:LHLabcorp Holdings Inc
06/05/202422h40Edgar (US Regulatory)Form PX14A6G - Notice of exempt solicitation submitted by non-managementNYSE:LHLabcorp Holdings Inc
29/04/202413h00PR Newswire (US)Labcorp Receives FDA Approval for First Companion Diagnostic for Use with Pfizer's Newly Approved Gene Therapy to Treat Patients with Hemophilia BNYSE:LHLabcorp Holdings Inc
25/04/202412h58PR Newswire (US)Labcorp Announces 2024 First Quarter ResultsNYSE:LHLabcorp Holdings Inc
25/04/202403h27PR Newswire (US)Labcorp Announces Winning Bid for Select Assets of InvitaeNYSE:LHLabcorp Holdings Inc
25/04/202403h19PR Newswire (US)Invitae Enters into Agreement with Labcorp for Sale of BusinessNYSE:LHLabcorp Holdings Inc
15/04/202413h00PR Newswire (US)Labcorp Announces First-of-Its-Kind Test for Early Indication of Neurodegenerative Diseases and Brain Injuries Using a Blood DrawNYSE:LHLabcorp Holdings Inc
11/04/202412h59PR Newswire (US)Labcorp Declares Quarterly DividendNYSE:LHLabcorp Holdings Inc
10/04/202412h49PR Newswire (US)Labcorp Receives FDA Emergency Use Authorization for Mpox PCR Test Home Collection KitNYSE:LHLabcorp Holdings Inc
08/04/202413h00PR Newswire (US)Labcorp Announces Expansion of Precision Oncology Portfolio to Support Pharmaceutical, Biopharma, and Clinical Research in Advancing Drug Development ProgramsNYSE:LHLabcorp Holdings Inc
05/04/202413h00PR Newswire (US)Labcorp Launches Labcorp® Plasma Detect™ Extending Leadership into Molecular Residual Disease (MRD) Clinical ResearchNYSE:LHLabcorp Holdings Inc
02/04/202413h00PR Newswire (US)Labcorp to Present Diverse Portfolio of Precision Oncology Research at the Annual Meeting of the American Association for Cancer ResearchNYSE:LHLabcorp Holdings Inc
01/04/202414h00Business WireXcell Biosciences Strengthens Cell and Gene Therapy Collaboration With LabcorpNYSE:LHLabcorp Holdings Inc
29/03/202414h00PR Newswire (US)The Prelude Network® Names Labcorp Its Preferred Genetic Carrier Screening LabNYSE:LHLabcorp Holdings Inc
28/03/202413h00PR Newswire (US)Labcorp Announces Acquisition of Select Assets of BioReference Health's Diagnostics BusinessNYSE:LHLabcorp Holdings Inc
 Showing the most relevant articles for your search:NYSE:LH

Dernières Valeurs Consultées

BIT
P1Z3E8
NLBNPIT1Z3E8 20351221 17...
NASDAQ
HUT
Hut 8
BIT
P20A83
NLBNPIT20A83 20240918 21...
EU
0019M
Morgan Stanley And Co In...
NEO
GOOG
Alphabet Inc CDR
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés